Lenvatinib plus everolimus for patients with metastatic kidney cancer
The treatment of heavily pretreated patients with metastatic kidney cancer [...]
The treatment of heavily pretreated patients with metastatic kidney cancer [...]
A recent study looked at the use of a combination [...]
Cabozantinib is a tyrosine kinase inhibitor that is used [...]
The Food and Drug Administration (FDA) in the United States [...]
Treatments for people with metastatic kidney cancer have changed over [...]
Kidney cancers often have mutations in a gene called the [...]
At the American Society of Clinical Oncology Genitourinary Cancers Conference [...]
At the 2022 European International Kidney Cancer Symposium (EIKCS) in [...]
The results from a recent phase 2 trial looked at [...]
Vascular endothelial growth factor (VEGF) tyrosine kinase inhibitors (TKI) are [...]